Prostate Cancer Clinical Trial

Personal Patient Profile – Prostate (P3P) II: Effectiveness-Implementation Trial in Diverse Health Care Networks

Summary

The purpose of this study is to determine whether using the P3P website can increase decisional preparation and satisfaction, and decrease decisional conflict, in men deciding how to manage early stage prostate cancer.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Biopsy-proven diagnosis of prostate cancer, T1 or T2 of any risk level
Biopsy done at enrolling site
Upcoming appointment with consulting specialist at enrolling study site
Able to read, write, understand English

Exclusion Criteria:

Two or more post-biopsy specialist consults
Begun treatment (or active surveillance)

Study is for people with:

Prostate Cancer

Estimated Enrollment:

392

Study ID:

NCT01844999

Recruitment Status:

Completed

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Kaiser Permanente - Souther California
Downey California, , United States
Kaiser Permanente - Southern California
Los Angeles California, , United States
Emory Healthcare
Atlanta Georgia, , United States
Beth Israel Deaconess Medical Center
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Prostate Cancer

Estimated Enrollment:

392

Study ID:

NCT01844999

Recruitment Status:

Completed

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider